These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3528846)

  • 1. [Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans].
    Korting HC; Schlaf-Maier U; Schäfer-Korting M
    Mykosen; 1986 Jul; 29(7):297-305. PubMed ID: 3528846
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketoconazole concentrations in human skin blister fluid and plasma.
    Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Sep; 43(9):1018-9. PubMed ID: 8240451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization of sensitivity tests to ketoconazole. Value of experience planning in the choice of a medium].
    Mary C; Blancard A; Goudard M; Quilici M; Regli P
    Ann Biol Clin (Paris); 1987; 45(6):680-4. PubMed ID: 3326440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correlation between biotype and antifungal sensitivity of Candida albicans].
    Korting HC; Dorsch R
    Mykosen; 1987 Nov; 30(11):512-9. PubMed ID: 3328045
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of dalbavancin in plasma and skin blister fluid.
    Nicolau DP; Sun HK; Seltzer E; Buckwalter M; Dowell JA
    J Antimicrob Chemother; 2007 Sep; 60(3):681-4. PubMed ID: 17631507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cantharidin-induced acantholysis. Dependence on epidermal respiration.
    Decker RH
    Arch Dermatol; 1966 Oct; 94(4):509-13. PubMed ID: 5950768
    [No Abstract]   [Full Text] [Related]  

  • 11. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serotype, sensitivity to ketoconazole and inhibition of pseudomycelial growth in Candida albicans.
    Auger P; Péloquin S; Joly J; Montplaisir S; Marquis G
    Mykosen; 1984 Oct; 27(10):498-505. PubMed ID: 6096709
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing.
    Le Moli S; Seminara R; D'Amelio R; Pontesilli O; Nisini R
    Boll Ist Sieroter Milan; 1983; 62(6):531-4. PubMed ID: 6329246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diffusion of lipid fractions through the barrier of cantharidin blisters in hyperlipidemias under conditions of clofibrate and rutinosid interaction].
    Szamer B
    Ann Acad Med Stetin; 1993; 39():87-101. PubMed ID: 8154625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of human serum on the postantifungal effect induced by therapeutic concentrations of ketoconazole and 5-fluorocytosine.
    Lima JE; Minguez F; Chiu ML; Garcia MT; Guardiola L; Prieto J
    J Chemother; 1995 Nov; 7 Suppl 4():38-9. PubMed ID: 8904100
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticandidal activity of flunarizine.
    Krajewska-Kułak E; Niczyporuk WW
    Mater Med Pol; 1993; 25(3-4):143-4. PubMed ID: 8072319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and skin blister fluid concentrations of metronidazole and its hydroxy metabolite after oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Pol J Pharmacol; 1996; 48(1):47-52. PubMed ID: 9112627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ketoconazole: pharmacological review].
    Sutter P
    Ther Umsch; 1984 Jun; 41(6):406-11. PubMed ID: 6087486
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbiological assay of ketoconazole in shampoo.
    Staub I; Schapoval EE; Bergold AM
    Int J Pharm; 2005 Mar; 292(1-2):195-9. PubMed ID: 15725566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium.
    Van Cutsem J; Borgers M; De Brabander M
    Mykosen; 1981 Oct; 24(10):596-602. PubMed ID: 6270550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.